Immune Strategies for Gastrointestinal Cancer
Immune Strategies for Gastrointestinal Cancer
English | 2023 | ISBN: 3031399439 | 534 Pages | PDF EPUB (True) | 11 MB
English | 2023 | ISBN: 3031399439 | 534 Pages | PDF EPUB (True) | 11 MB
Immunotherapy has celebrated some astonishing therapeutic successes in a variety of cancer types and is becoming increasingly relevant in daily clinical practice. Currently, the predominant class of immunotherapeutic drugs is the so-called checkpoint inhibitors, which disengage the physiological brakes on the immune system, enabling a more effective anti-cancer immune response. Malignancies of the gastrointestinal tract, which account for the majority of cancer cases worldwide, are a major cause of morbidity and mortality, creating an urgent need for more effective therapies. A large number of clinical trials have evaluated the efficacy of cancer immunotherapy in gastrointestinal malignancies and demonstrated its potential in certain subsets of patients.